IT1237429B - Derivati ciclici e loro metaboliti, loro preparazione e composizioni farmaceutiche che li contengono. - Google Patents

Derivati ciclici e loro metaboliti, loro preparazione e composizioni farmaceutiche che li contengono.

Info

Publication number
IT1237429B
IT1237429B IT04861089A IT4861089A IT1237429B IT 1237429 B IT1237429 B IT 1237429B IT 04861089 A IT04861089 A IT 04861089A IT 4861089 A IT4861089 A IT 4861089A IT 1237429 B IT1237429 B IT 1237429B
Authority
IT
Italy
Prior art keywords
metabolites
preparation
pharmaceutical compositions
compositions containing
cyclic derivatives
Prior art date
Application number
IT04861089A
Other languages
English (en)
Other versions
IT8948610A0 (it
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8948610A0 publication Critical patent/IT8948610A0/it
Application granted granted Critical
Publication of IT1237429B publication Critical patent/IT1237429B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/445The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT04861089A 1988-11-29 1989-11-29 Derivati ciclici e loro metaboliti, loro preparazione e composizioni farmaceutiche che li contengono. IT1237429B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3840185 1988-11-29
DE3917779 1989-05-31

Publications (2)

Publication Number Publication Date
IT8948610A0 IT8948610A0 (it) 1989-11-29
IT1237429B true IT1237429B (it) 1993-06-04

Family

ID=25874647

Family Applications (1)

Application Number Title Priority Date Filing Date
IT04861089A IT1237429B (it) 1988-11-29 1989-11-29 Derivati ciclici e loro metaboliti, loro preparazione e composizioni farmaceutiche che li contengono.

Country Status (6)

Country Link
JP (1) JPH02275884A (it)
BE (1) BE1003436A3 (it)
CH (1) CH678855A5 (it)
FR (1) FR2639637A1 (it)
GB (1) GB2225576B (it)
IT (1) IT1237429B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2245891A (en) * 1990-07-09 1992-01-15 Fujisawa Pharmaceutical Co Tricyclo compounds
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
US5023262A (en) * 1990-08-14 1991-06-11 American Home Products Corporation Hydrogenated rapamycin derivatives
CA2051872A1 (en) * 1990-09-24 1992-03-25 Kevin M. Byrne Directed biosynthesis process for prolyl-immunomycin
US5527820A (en) * 1992-06-23 1996-06-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Antibiotics having immunosuppressive activity, delaminomycins and processes for the production of the same
WO1994000438A1 (en) * 1992-06-24 1994-01-06 Yamanouchi Pharmaceutical Co., Ltd. Novel benzodiazepine derivative
ZA200406350B (en) 2002-02-13 2006-11-29 Teva Gyogyszergyar Reszveny Tarsasag Method for extracting a macrolide from biomatter
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0323042A1 (en) * 1987-12-09 1989-07-05 FISONS plc Process to macrocyclic compounds
EP0349061B1 (en) * 1988-06-29 1995-03-29 Merck & Co. Inc. Immunosuppressant agent
US4981792A (en) * 1988-06-29 1991-01-01 Merck & Co., Inc. Immunosuppressant compound
EP0353678B1 (en) * 1988-08-01 1995-12-13 Fujisawa Pharmaceutical Co., Ltd. FR-901154 and FR-901155 substances, a process for their production
EP0358508A3 (en) * 1988-09-08 1991-03-20 Merck & Co. Inc. Novel immunosuppressant compound

Also Published As

Publication number Publication date
FR2639637B1 (it) 1994-08-19
FR2639637A1 (fr) 1990-06-01
BE1003436A3 (fr) 1992-03-24
CH678855A5 (it) 1991-11-15
GB8926787D0 (en) 1990-01-17
GB2225576A (en) 1990-06-06
JPH02275884A (ja) 1990-11-09
IT8948610A0 (it) 1989-11-29
GB2225576B (en) 1992-07-01

Similar Documents

Publication Publication Date Title
IT1203806B (it) Derivati del tiazolo,loro preparazione e composizioni farmaceutiche che li contengono
IT8420057A0 (it) Derivati della tiazolina, procedimento per la loro preparazione e loro composizioni farmaceutiche.
IT1213246B (it) Derivati della 6-vinil-furo-(3,4-c)-piridina, loro preparazione e composizioni farmaceutiche che li contengono.
IT8322565A0 (it) Derivati della desossiuridina, loro preparazione e loro impiego come medicamenti.
IT8720619A0 (it) Derivati 1-(idrossistiril)-5h2,3-benzodiazepinici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1219542B (it) Derivati pepticidi,loro preparazione e loro impiego come medicamenti
IT1237429B (it) Derivati ciclici e loro metaboliti, loro preparazione e composizioni farmaceutiche che li contengono.
ITMI912745A0 (it) Derivati 5h-benzodiazepinici, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
IT8319027A0 (it) Derivati amino-alchil-solfonici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1190401B (it) Derivati di vitamina d,composizioni farmaceutiche che li contengono e loro precursori
IT1243203B (it) Derivati aminopropanolici, procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI910846A1 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1200079B (it) Derivati della naftossazina, loro preparazione, loro applicazione come medicamenti e composizioni farmaceutiche che li contengono
IT1216120B (it) Derivati n_cicloalchilaminoetilbenzamidici, loro preparazione e composizioni farmaceutiche che li contengono.
IT1208046B (it) Derivati 3-(idrossimetil)isochinolinici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1243751B (it) Derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1227920B (it) Derivati diossazocinici, loro preparazione e composizioni che li contengono
ITFI920134A1 (it) Derivati 7-neopentil xantinici, loro preparazione e composizioni farmaceutiche che li contengono
IT1208533B (it) Derivati di apovincaminolo, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8323844A0 (it) Derivati della cisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT9021135A0 (it) Derivati tienopirimidinonacrilici, loro preparazione e composizioni farmaceutiche che li contengono
IT8819183A0 (it) Derivati della bromesina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1227457B (it) Nuovi ottaidroindenofuran derivati, loro preparazione e composizioni terapeutiche che li contengono.
IT8420537A0 (it) Derivati della nomifensina, loro preparazione e composizioni farmaceutiche che li contengono.
IT8720493A0 (it) Derivati cefalosporinici, loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19941129